Gertrude B. Elion, a chemist working in the research laboratories of Burroughs Wellcome, revolutionized childhood cancer ...

SAN FRANCISCO -- Almost 80% of patients with heavily pretreated advanced/metastatic pancreatic cancer achieved disease ...

Suleika Jaouad's leukemia experience highlights the importance of mindfulness and support networks in managing the disease.

The FDA designates ARB1002 as an orphan drug, highlighting its potential as a novel treatment for pancreatic cancer amid ...

A new drug combination shows unexpected synergy against liver fibrosis. A new study reveals that using two drugs together ...

By using a patient's DNA to craft personalized drug treatments, doctors can increase the efficacy and better the outcomes of fighting cancer.

Researchers at University of California San Diego School of Medicine have led the first clinical trial in the world to show ...

Arbele Pte Ltd.’s ARB-1002 has been awarded orphan drug designation by the FDA for the treatment of pancreatic cancer. ARB-1002 is an antibody-drug conjugate comprising an anti-CDH17 monoclonal ...

Researchers at University of California San Diego School of Medicine have led the first clinical trial in the world to show that cancer drug treatments can be safely and effectively personalized based ...

SAN FRANCISCO, CALIFORNIA / ACCESS Newswire / January 2, 2026 / Jaguar Health, Inc. (NASDAQ:JAGX) ("Jaguar") today ...

Megestrol, which helps treat hot flashes associated with menopause, may have the added benefit of slowing the growth of ...

New research presented at the 2025 International Kidney Cancer Symposium found that patients with localized renal cell ...